Advances of medicated management for tic disorder in children / 中华实用儿科临床杂志

ABSTRACT

In recent years, more attention has been paid to the treatment of tic disorder (TD) in children owing to a decrease in onset of age and cure rate and an increase in refractory cases.The present article reviews advances in drug therapies for TD, including α2-adrenergic receptors, dopamine receptor D blockers, typical and atypical antipsychotic drugs, antiepileptic drugs, and botulinum toxin type A, as well as the sustainable treatment up to adulthood.It also highlights the regular treatment, full-course treatment, and individualized treatment for TD in children.